Schepens Eye Research Institute - Click to return to home page

2005 Faculty Publications

  1. Abelson MB, Gomes PJ, Vogelson CT, Pasquine TA, Turner FD, Wells DT, Robertson SM. Effects of a new formulation of olopatadine ophthalmic solution on nasal symptoms relative to placebo in two studies involving subjects with allergic conjunctivitis or rhinoconjunctivitis. Curr Med Res Opin. 21:683-691, 2005 May.

  2. Afshari NA, Schirra F, Rapoza PA, Talamo JH, Ludwig K, Adelman RA, Kenyon KR. Laser in situ keratomileusis outcomes following radial keratotomy, astigmatic keratotomy, photorefractive keratectomy, and penetrating keratoplasty. J Cataract Refract Surg. 31:2093-2100, 2005 Nov.

  3. Ahmad OF, Hirose T. Retinal detachment with macular holes in infants with retinopathy of prematurity. Arch Ophthalmol. 123:54-57, 2005 Jan.

  4. Albe E, Escalona E, Rajagopal R, Javier JA, Chang JH, Azar DT. Proteomic identification of activin receptor-like kinase-1 as a differentially expressed protein during hyaloid vascular system regression. FEBS Lett. 579:5481-5486, 2005 Oct 24.

  5. Apfelbaum HL, Apfelbaum DH, Woods RL, Peli E. The effect of edge filtering on vision multiplexing. SID Int Symposium, Dig Tech Papers, Society for Information Display. 36:1398-1401, 2005.

  6. Arboleda-Velasquez JF, Rampal R, Fung E, Darland DC, Liu M, Martinez MC, Donahue CP, Navarro-Gonzalez MF, Libby P,

  7. D'Amore PA, Aikawa M, Haltiwanger RS, Kosik KS. CADASIL mutations impair Notch3 glycosylation by Fringe. Hum Mol Genet. 14:1631-1639, 2005 Jun 15.

  8. Arroyo JG, Bula DV, Lui Y, Chen DF. Retinal biopsy techniques for the removal of retinal tissue fragments. Ophthalmic Surg Lasers Imaging. 36:76-78,2005 Jan-Feb.

  9. Arroyo JG, Yang L, Bula D, Chen DF. Photoreceptor apoptosis in human retinal detachment. Am J Ophthalmol. 139:605-610, 2005 Apr.

  10. Baker CI, Peli E, Knouf N, Kanwisher NG. Reorganization of visual processing in macular degeneration. J Neurosci. 25:614-618, 2005 Jan.

  11. Balaram M, Rashid S, Dana R. Chronic ocular surface disease after allogeneic bone marrow transplantation. Ocular Surface 3:203-210, 2005 Oct.

  12. Barabas J, Woods R, Peli E. Walking simulator for evaluation of ophthalmic devices. In Rogowitz BE, Pappas TN, Daly SJ, editors. Human Vision and Electronic Imaging X. Proceedings of SPIE-IS&T Electronic Imaging, volume 5666, 2005, pp. 424-433.

  13. Barabino S, Raghavan A, Loeffler J, Dana R. Radiotherapy-Induced Ocular Surface Disease. Cornea. 24:909-914, 2005 Nov.

  14. Barabino S, Rolando M, Camicione P, Chen W, Calabria G. Effects of a 0.9% sodium chloride ophthalmic solution on the ocular surface of symptomatic contact lens wearers.Can J Ophthalmol. 40:45-50, 2005 Feb.

  15. Barabino S, Shen L, Chen L, Rashid S, Rolando M, Dana MR. The controlled-environment chamber: a new mouse model of dry eye. Invest Ophthalmol Vis Sci. 46:2766-2771, 2005 Aug.

  16. Barouch FC, Colby KA. Corneal and conjunctival degenerations. In Foster CS, Azar DT, Dohlman CH, editors. Smolin and Thoft's The Cornea: Scientific Foundations and Cinical Practice. 4th edition. Philadelphia, Lippincott Williams & Wilkins, 2005, pp. 875-888.

  17. Benavides JM, Webb RH. Optical characterization of ultrabright LEDs. Appl Opt. 44:4000-4003, 2005 Jul 1.

  18. Berger W, Abelson MB, Gomes PJ, Beck M, Kimura S, Westbrook T, Storms W, Galant S. Effects of adjuvant therapy with 0.1% olopatadine hydrochloride ophthalmic solution on quality of life in patients with allergic rhinitis using systemic or nasal therapy. Ann Allergy Asthma Immunol. 95:361-371, 2005 Oct.

  19. Bowers AR, Apfelbaum DH, Peli E. Bioptic telescopes meet the needs of drivers with moderate visual acuity loss.Invest Ophthalmol Vis Sci. 46:66-74, 2005 Jan.

  20. Bowers A, Peli E. Assessing driving performance with moderate visual field loss. Proceedings of the 3rd International Driving Symposium on Human Factors in Driver Assessment, Training, and Vehicle Design, Rockport, Maine, 2005,pp. 33-40.

  21. Bowers A, Peli E, Elgin J, McGwin G Jr, Owsley C. On-road driving with moderate visual field loss. Optom Vis Sci. 82:657-667, 2005 Aug.

  22. Chang JH, Javier JA, Chang GY, Oliveira HB, Azar DT. Functional characterization of neostatins, the MMP-derived, enzymatic cleavage products of type XVIII collagen.FEBS Lett. 579:3601-3606, 2005 Jul 4.

  23. Chen L, Cursiefen C, Barabino S, Zhang Q, Dana MR. Novel expression and characterization of lymphatic vessel endothelial hyaluronate receptor 1 (LYVE-1) by conjunctival cells. Invest Ophthalmol Vis Sci. 46:4536-4540, 2005 Dec.

  24. Chen LL, Johansson JK, Hodges RR, Zoukhri D, Ghinelli E, Rios JD, Dartt DA. Differential effects of the EGF family of growth factors on protein secretion, MAPK activation, and intracellular calcium concentration in rat lacrimal gland. Exp Eye Res. 80:379-389, 2005 Mar.

  25. Chen W, Qu J, Wang QM, Lu F, Barabino S. Automated lamellar keratoplasty for recurrent granular corneal dystrophy after phototherapeutic keratectomy. J Refract Surg. 21:288-293, 2005 May-Jun.

  26. Chen WL, Harris DL, Joyce NC. Effects of SOV-induced phosphatase inhibition and expression of protein tyrosine phosphatases in rat corneal endothelial cells. Exp Eye Res. 81:570-580, 2005 Nov.

  27. Cheong AM, Lovie-Kitchin JE, Bowers AR, Brown B. Short-term in-office practice improves reading performance with stand magnifiers for people with AMD. Optom Vis Sci. 82:114-127, 2005 Feb.

  28. Cho KS, Yang L, Lu B, Feng Ma H, Huang X, Pekny M, Chen DF. Re-establishing the regenerative potential of central nervous system axons in postnatal mice. J Cell Sci. 118:863-872, 2005 Mar 1.

  29. Cox CR, Coburn PS, Gilmore MS. Enterococcal cytolysin: A novel two component peptide system that serves as a bacterial defense against eukaryotic and prokaryotic cells. Curr Protein Pept Sci. 6:77-84, 2005 Feb.

  30. Cursiefen C, Ikeda S, Nishina PM, Smith RS, Ikeda A, Jackson D, Mo JS, Chen L, Dana MR, Pytowski B, Kruse FE, Streilein JW. Spontaneous corneal hem- and lymphangiogenesis in mice with destrin-mutation depend on VEGFR3 signaling. Am J Pathol. 166:1367-1377, 2005 May.

  31. Dana R. Corneal antigen presentation: Molecular regulation and functional implications. Ocular Surface 3:S169-S172, 2005 Suppl. Oct.

  32. Dana MR, Hamrah P. Corneal antigen-presenting cells: function and identity. In Zierhut M, Stern ME, Sullivan DA, editors. Immunology of the lacrimal gland, tear film and ocular surface. London, Taylor and Francis, 2005, pp. 141-149.

  33. Detwiller KY, Fernando NT, Segal NH, Ryeom SW, D'Amore PA, Yoon SS. Analysis of hypoxia-related gene expression in sarcomas and effect of hypoxia on RNA interference of vascular endothelial cell growth factor A. Cancer Res 65: 5881-5889, 2005 Jul 1.

  34. Donnenfeld ED, Kim T, Holland EJ, Azar DT, Palmon FR, Rubenstein JB, Daya S, Yoo SH; American Society of Cataract and Refractive Surgery Cornea Clinical Committee. ASCRS White Paper: Management of infectious keratitis following laser in situ keratomileusis. J Cataract Refract Surg. 31:2008-2011, 2005 Oct.

  35. Durand ML, Kim IK, D'Amico DJ, Loewenstein JI, Tobin EH, Kieval SJ, Martin SS, Azar DT, Miller FS 3rd, Lujan BJ, Miller JW. Successful treatment of Fusarium endophthalmitis with voriconazole and Aspergillus endophthalmitis with voriconazole plus caspofungin. Am J Ophthalmol. 140:552-554, 2005 Sep.

  36. Engelbert M, Gilmore MS. Fas ligand but not complement is critical for control of experimental Staphylococcus aureus endophthalmitis. Invest Ophthalmol Vis Sci. 46:2479-2486, 2005 Jul.

  37. Feit-Leichman RA, Kinouchi R, Takeda M, Fan Z, Mohr S, Kern TS, Chen DF. Vascular damage in a mouse model of diabetic retinopathy: relation to neuronal and glial changes. Invest Ophthalmol Vis Sci. 46:4281-4287, 2005 Nov.

  38. Fullerton M, Peli E. MPEG based image enhancement for the visually impaired: Implementation on a general-purpose PC platform. SID 05 Digest of Technical Papers, 2005, pp.402-405.

  39. Garcia-Perez MA, Giorgi RG, Woods RL, Peli E. Thresholds vary between spatial and temporal forced-choice paradigms: The case of lateral interactions in peripheral vision.

  40. Spatial Vis 18:99-127, 2005

  41. Gerhardinger C, Costa MB, Coulombe MC, Toth I, Hoehn T, Grosu P. Expression of acute-phase response proteins in retinal muller cells in diabetes. Invest Ophthalmol Vis Sci. 46:349-357, 2005 Jan.

  42. Gilmore MS, Haas W. The selective advantage of microbial fratricide. Proc Natl Acad Sci U S A. 102:8401-8402, 2005 Jun 14.

  43. Gipson IK. Human endocervical mucins. In Croxatto HB, Schürmann R, Fuhrmann U, Schellschmidt I, editors. New Mechanisms for Tissue-Selective Estrogen-Free Contraception. Ernst Schering Research Foundation Workshop, volume 52. Berlin/Heidelberg/New York, Springer, 2005, pp.219-244.

  44. Gipson IK, Joyce NJ, Zieske JD. The anatomy and cell biology of the human cornea, limbus, conjunctiva, and adnexa. In Foster CS, Azar DT, Dohlman CH, editors. Smolen & Thoft's The Cornea. 4th edition. Lippincott, Williams & Wilkins, Philadelphia, 2005, pp.1-35.

  45. Gregory MS, Koh S, Huang E, Saff RR, Marshak-Rothstein A, Mukai S, Ksander BR. A novel treatment for ocular tumors using membrane FasL vesicles to activate innate immunity and terminate immune privilege. Invest Ophthalmol Vis Sci. 46:2495-2502, 2005 Jul.

  46. Greiner JV, Udell IJ. A comparison of the clinical efficacy of pheniramine maleate/naphazoline hydrochloride ophthalmic solution and olopatadine hydrochloride ophthalmic solution in the conjunctival allergen challenge model. Clin Ther. 27:568-577,2005 May.

  47. Gulati A, Dana R. The dry eye. In Wallace, DJ, Sjogren’s Syndrome Foundation. The New Sjogren’s Sydrome Handbook, 3rd edition. New York, Oxford University Press, 2005, pp. 41-51.

  48. Gur M, Kagan I, Snodderly DM. Orientation and direction selectivity of neurons in V1 of alert monkeys: Functional relationships and laminar distributions. Cerebral Cortex 15:1207-1221, 2005 Aug.

  49. Hodges RR, Shatos MA, Tarko RS, Vrouvlianis J, Gu J, Dartt DA. Nitric oxide and cGMP mediate {alpha}1D-adrenergic receptor-stimulated protein secretion and p42/p44 MAPK activation in rat lacrimal gland. Invest Ophthalmol Vis Sci. 46:2781-2789, 2005 Aug.

  50. Hopfer U, Fukai N, Hopfer H, Wolf G, Joyce N, Li E, Olsen BR. Targeted disruption of Col8a1 and Col8a2 genes in mice leads to anterior segment abnormalities in the eye. FASEB J. 19:1232-1244, 2005 Aug.

  51. Hori Y, Spurr-Michaud SJ, Russo CL, Argueso P, Gipson IK. Effect of retinoic acid on gene expression in human conjunctival epithelium: Secretory phospholipase A2 mediates retinoic acid induction of MUC16. Invest Ophthalmol Vis Sci.46:4050-4061, 2005 Nov.

  52. Hovland PG, Trempe C. Genomic investigations of posterior uveal melanoma. Semin Ophthalmol. 20:231-238, 2005 Oct-Dec.

  53. Hutcheon AE, Guo XQ, Stepp MA, Simon KJ, Weinreb PH, Violette SM, Zieske JD. Effect of wound type on Smad 2 and 4 translocation. Invest Ophthalmol Vis Sci. 46:2362-2368, 2005 Jul.

  54. Im E, Venkatakrishnan A, Kazlauskas A. Cathepsin B regulates the intrinsic angiogenic threshold of endothelial cells. Mol Biol Cell. 16:3488-3500, 2005 Aug.

  55. Jerdeva GV, Yarber FA, Trousdale MD, Rhodes CJ, Okamoto CT, Dartt DA, Hamm-Alvarez SF. Dominant-negative PKC-epsilon impairs apical actin remodeling in parallel with inhibition of carbachol-stimulated secretion in rabbit lacrimal acini. Am J Physiol-Cell Physiol. 289:C1052-C1068, 2005 Oct.

  56. Jiao J, Huang X, Feit-Leithman RA, Neve RL, Snider W, Dartt DA, Chen DF. Bcl-2 enhances Ca(2+) signaling to support the intrinsic regenerative capacity of CNS axons. Embo J. 24:1068-1078, 2005 Mar 9.

  57. Johnson EJ, Neuringer M, Russell RM, Schalch W, Snodderly DM. Nutritional manipulation of primate retinas, III: Effects of lutein or zeaxanthin supplementation on adipose tissue and retina of xanthophyll-free monkeys. Invest Ophthalmol Vis Sci. 46:692-702, 2005 Feb.

  58. Joyce NC. Cell cycle status in human corneal endothelium. Exp Eye Res. 81:629-638, 2005 Dec.

  59. Kazlauskas A. The priming/completion paradigm to explain growth factor-dependent cell cycle progression. Growth Factors. 23:203-210, 2005 Sep.

  60. Kim CY, Masli S, Wayne Streilein J. Qa-1, a nonclassical MHC molecule with immunomodulatory functions, is ubiquitously expressed in the immune-privileged anterior chamber of the eye. Ocul Immunol Inflamm. 13:271-277, 2005 Aug.

  61. Kitaichi N, Namba K, Taylor AW. Inducible immune regulation following autoimmune disease in the immune-privileged eye. J Leukoc Biol. 77:496-502, 2005 Apr.

  62. Kobayakawa S, Jett BD, Gilmore MS. Biofilm formation by enterococcus faecalis on intraocular lens material. Curr Eye Res. 30:741-745, 2005 Sep.

  63. Konomi K, Zhu C, Harris D, Joyce NC. Comparison of the proliferative capacity of human corneal endothelial cells from the central and peripheral areas. Invest Ophthalmol Vis Sci. 46:4086-4091, 2005 Nov.

  64. Koprivica V, Cho KS, Park JB, Yiu G, Atwal J, Gore B, Kim JA, Lin E, Tessier-Lavigne M, Chen DF, He ZG. EGFR activation mediates inhibition of axon regeneration by myelin and chondroitin sulfate proteoglycans. Science 310: 106-110, 2005 Oct 7.

  65. Korb DR, Herman JP, Greiner JV, Scaffidi RC, Finnemore VM, Exford JM, Blackie CA, Douglass T. Lid wiper epitheliopathy and dry eye symptoms. Eye Contact Lens. 31:2-8, 2005 Jan.

  66. Korb DR, Scaffidi RC, Greiner JV, Kenyon KR, Herman JP, Blackie CA, Glonek T, Case CL, Finnemore VM, Douglass T. The effect of two novel lubricant eye drops on tear film lipid layer thickness in subjects with dry eye symptoms. Optom Vis Sci. 82:594-601, 2005 Jul.

  67. Ksander BR. Bruce R. Ksander - In memoriam [of J. Wayne Streilein]. Cornea 24:366-367, 2005 Apr.

  68. Lavik EB, Klassen H, Warfvinge K, Langer R, Young MJ. Fabrication of degradable polymer scaffolds to direct the integration and differentiation of retinal progenitors. Biomaterials 26:3187-3196, 2005 Jun.

  69. Lee JS, Kim JH, Jang IH, Kim HS, Han JM, Kazlauskas A, Yagisawa H, Suh PG, Ryu SH. Phosphatidylinositol (3,4,5)-trisphosphate specifically interacts with the phox homology domain of phospholipase D1 and stimulates its activity. J Cell Sci. 118:4405-4413, 2005 Oct 1.

  70. Leung IY, Sandstrom MM, Zucker CL, Neuringer M, Max Snodderly D. Nutritional manipulation of primate retinas. IV. Effects of n-3 fatty acids, lutein, and zeaxanthin on S-cones and rods in the foveal region. Exp Eye Res. 81:513-529, 2005 Nov.

  71. Levenberg S, Rouwkema J, Macdonald M, Garfein ES, Kohane DS, Darland DC, Marini R, van Blitterswijk CA, Mulligan RC, D'Amore PA, Langer R. Engineering vascularized skeletal muscle tissue. Nat Biotechnol. 23:879-884, 2005 Jul.

  72. Lin HH, Faunce DE, Stacey M, Terajewicz A, Nakamura T, Zhang-Hoover J, Kerley M, Mucenski ML, Gordon S, Stein-Streilein J. The macrophage F4/80 receptor is required for the induction of antigen-specific efferent regulatory T cells in peripheral tolerance. J Exp Med 201:1615-1625, 2005 May 16.

  73. Loureiro RM, D'Amore PA. Transcriptional regulation of vascular endothelial growth factor in cancer. Cytokine Growth Factor Rev. 16:77-89, 2005 Feb.

  74. Loureiro RM, Maharaj AS, Dankort D, Muller WJ, D'Amore PA. ErbB2 overexpression in mammary cells upregulates VEGF through the core promoter. Biochem Biophys Res Commun. 326:455-465, 2005 Jan.

  75. Luo G, Rensing N, Weststrate E, Peli E. Registration of an on-axis see-through head-mounted display and camera system. Opt Eng 44: 24002-1-7, 2005 Feb.

  76. Maruyama K, Ii M, Cursiefen C, Jackson DG, Keino H, Tomita M, Van Rooijen N, Takenaka H, D'Amore PA, Stein-Streilein J, Losordo DW, Streilein JW. Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. J Clin Invest. 115:2363-2372, 2005 Sep 1.

  77. McAlister JC, Joyce NC, Harris DL, Ali RR, Larkin DFP. Induction of replication in human corneal endothelial cells by E2F2 transcription factor cDNA transfer. Invest Ophthalmol Vis Sci. 46:3597-3603, 2005 Oct.

  78. McDermott AM, Perez V, Huang AJW, Pflugfelder SC, Stern ME, Baudouin C, Beuerman RW, Burns AR, Calder VL, Calonge M, Chodosh J, Coster DJ, Dana R, Hazlett LD, Jones DB, Kim SK, Knop E, Li D-Q, Mitchell BM, Niederkorn JY, Pearlman E, Wilhelmus KR, Kurie E. Pathways of corneal and ocular surface inflammation: a perspective from the Cullen symposium. Ocular Surface 3:S131-S138, 2005 Suppl.Oct.

  79. Mellem-Kairala MB, Elsner AE, Weber A, Simmons RB, Burns SA. Improved contrast of peripapillary hyperpigmentation using polarization analysis. Invest Ophthalmol Vis Sci. 46:1099-1106, 2005 Mar.

  80. Menke MN, Feke GT. Assessment of the effects of morphological changes related to age-related macular degeneration on optical coherence tomography retinal thickness measurements. Ophthalmic Surg Lasers Imaging. 36:310-314, 2005 Jul-Aug.

  81. Menke MN, Feke GT, Trempe CL. OCT Measurements in Patients with Optic Disc Edema. Invest Ophthalmol Vis Sci. 46:3807-3811, 2005 Oct.

  82. Menke MN, Sato E, Van De Velde FJ, Feke GT. Combined use of SLO microperimetry and OCT for retinal functional and structural testing. Graefes Arch Clin Exp Ophthalmol. 25: 1-5, 2005 Aug.

  83. Miljanovic B, Trivedi KA, Dana MR, Gilbard JP, Buring JE, Schaumberg DA. Relation between dietary n-3 and n-6 fatty acids and clinically diagnosed dry eye syndrome in women. Am J Clin Nutr 82:887-893, 2005 Oct.

  84. Mo, J-S. Streilein JW. Analysis of immune privilege in eyes with mycobacteria tuberculosa adjuvant-induced uveitis. Ocul Immunol Inflamm. 13:139-147, 2005 Apr-Jun.

  85. Morris PN, Dunmore BJ, Tadros A, Marchuk DA, Darland DC, D'Amore PA, Brindle NPJ. Functional analysis of a mutant form of the receptor tyrosine kinase Tie2 causing venous malformations. J Mol Med. 83:58-63, 2005 Jan.

  86. Nakamura T, Terajewicz A, Stein-Streilein J. Mechanisms of peripheral tolerance following intracameral inoculation are independent of IL-13 or STAT6. J Immunol. 175:2643-2646, 2005 Aug 15.

  87. Netto MV, Mohan RR, Ambrosio R, Hutcheon AEK, Zieske JD, Wilson SE. Wound healing in the cornea - A review of refractive surgery complications and new prospects for therapy. Cornea 24:509-522, 2005 Jul.

  88. Nguyen ATQ, Colby KA. Pigmented tumors of the cornea and conjunctiva. In Foster CS, Azar DT, Dohlman CH, editors. Smolin and Thoft's The Cornea: Scientific Foundations and Cinical Practice. 4th Edition. Philadelphia, Lippincott Williams & Wilkins, 2005, pp. 769-780.

  89. Ono SJ, Abelson MB. Allergic conjunctivitis: Update on pathophysiology and prospects for future treatment. J Allergy Clin Immunol. 115:118-122, 2005 Jan.

  90. Osawa H, Streilein JW. MHC Class I and II antigens as targets of rejection in penetrating keratoplasty in low- and high-risk mouse eyes. Cornea 24:312-318, 2005 Apr.

  91. Ousler GW, Gomes PJ, Welch D, Abelson MB. Methodologies for the study of ocular surface disease. Ocular Surface 3:143-154, 2005 Jul.

  92. Peli E. Recognition performance and perceived quality of video enhanced for the visually impaired. Ophthalmic Physiol Opt. 25:543-555, 2005 Nov.

  93. Peli E, Bowers AR, Mandel AJ, Higgins KE, Goldstein RB, Bobrow L. Design of driving simulator performance evaluations for driving with vision impairments and visual aids. Transportation Research Record 1937:128-135, 2005.

  94. Peli E, Bowers AR, Mandel AJ, Higgins K, Goldstein R, Bobrow L. The design of driving simulator performance evaluations for driving with vision impairments and visual aids. TRB 2005 Annual Meeting, Compendium of Papers CD-ROM, 05-2578. Transportation Research Board, Washington DC, 2005.

  95. Peli E, Goldstein R, Woods RW. Scanpaths of motion sequences: where people look when watching movies. Proceedings of the Fourth Starkfest Conference on Vision and Movement in Man and Machines, School of Optometry, UC Berkeley, 2005, pp.18-21.

  96. Prieto PM, McLellan JS, Burns SA. Investigating the light absorption in a single pass through the photoreceptor layer by means of the lipofuscin fluorescence. Vis Res. 45:1957-1965, 2005 Jul.

  97. Remky A. Elsner AE. Blue on yellow perimetry with scanning laser ophthalmoscopy in patients with age related macular disease. Br J Ophthalmol. 89:464-469, 2005 Apr.

  98. Richards SM, Jensen RV, Liu M, Sullivan BD, Lombardi MJ, Rowley P, Schirra F, Treister NS, Suzuki T, Steagall RJ, Yamagami H, Sullivan DA. Influence of sex on gene expression in the mouse lacrimal gland. Exp Eye Res 2005 Jun 23 [Epub ahead of print]. Published in print: Exp Eye Res. 82:13-23, 2006 Jan.

  99. Richards SM, Liu M, Jensen RV, Schirra F, Yamagami H, Lombardi MJ, Rowley P, Treister NS, Suzuki T, Sullivan BD, Sullivan DA. Androgen regulation of gene expression in the mouse lacrimal gland. J Steroid Biochem Mol Biol. 96:401-413, 2005 Sep.

  100. Rios JD, Horikawa Y, Chen LL, Kublin CL, Hodges RR, Dartt DA, Zoukhri D. Age-dependent alterations in mouse exorbital lacrimal gland structure,innervation and secretory response. Exp Eye Res. 80:477-491, 2005 Apr.

  101. Roldan-Pallares M, Ambit Avila MI, Refojo MF. The use of boric acid solution to help in the removal of biodegraded Miragel episcleral buckles. Retina 25:90-93, 2005 Jan.

  102. Sakaguchi DS, Van Hoffelen SJ, Grozdanic SD, Kwon YH, Kardon RH, Young MJ. Neural progenitor cell transplants into the developing and mature central nervous system. Ann NY Acad Sci. 1049:118-134 2005 May.

  103. Schaumberg DA, Glynn RJ, Jenkins AJ, Lyons TJ, Rifai N, Manson JE, Ridker PM, Nathan DM. Effect of intensive glycemic control on levels of markers of inflammation in type 1 diabetes mellitus in the diabetes control and complications trial. Circulation 111:2446-2453, 2005 May 17

  104. Schirra F, Suzuki T, Richards SM, Jensen RV, Liu M, Lombardi MJ, Rowley P, Treister NS, Sullivan DA. Androgen control of gene expression in the mouse meibomian gland. Invest Ophthalmol Vis Sci. 46:3666-3675, 2005 Oct.

  105. Schwartz PH, Nethercott H, Kirov II, Ziaeian B, Young MJ, Klassen H. Expression of neurodevelopmental markers by cultured porcine neural precursor cells. Stem Cells 23: 1286-1294, 2005 Oct.

  106. Shurman DL, Glazewski L, Gumpert A, Zieske JD, Richard G. In vivo and in vitro expression of connexins in the human corneal epithelium. Invest Ophthalmol Vis Sci. 46:1957-1965, 2005 Jun.

  107. Sliney D, Aron-Rosa D, Delori F, Fankhauser F, Landry R, Mainster M, Marshall J, Rassow B, Stuck B, Trokel S, West TM, Wolffe M. Adjustment of guidelines for exposure of the eye to optical radiation from ocular instruments: Statement from a task group of the International Commission on Non-Ionizing Radiation Protection (ICNIRP). Appl Opt. 44:2162-76, 2005 Apr 10.

  108. Stein-Streilein J. A privileged view of NKT cells and peripheral tolerance through the eye. Ocul Immunol Inflamm. 13:111-117, 2005 Apr-Jun. Stepp, MA, Zieske, JD. The corneal epithelial stem cell niche. Ocular Surface 3:15-26, 2005 Jan.

  109. Sullivan DA, Schaumberg DA, Schirra F, Suzuki T, Liu M, Richards SM, Sullivan RM, Dana MR, Sullivan BD. Sex, sex steroids and dry eye syndromes. In Zierhut M, Stern ME, Sullivan DA, editors. Immunology of the Lacrimal Gland, Tear Film and Ocular Surface. London, Taylor & Francis, 2005, pp. 161-181.

  110. Sun W, Gerhardinger C, Dagher Z, Hoehn T, Lorenzi M. Aspirin at low-intermediate concentrations protects retinal vessels in experimental diabetic retinopathy through non-platelet-mediated effects. Diabetes. 54:3418-3426, 2005 Dec.

  111. Suzuki T, Sullivan DA. Estrogen stimulation of proinflammatory cytokine and matrix metalloproteinase gene expression in human corneal epithelial cells. Cornea 24:1004-1009, 2005 Nov.

  112. Tanaka K, Yamagami S, Streilein JW. Evidence that T-helper type 2 cell-derived cytokines and eosinophils contribute to acute rejection of orthotopic corneal xenografts in mice. Transplantation 79:1317-1323, 2005 May 27.

  113. Taneri S, Azar DT. LASEK: results after 1 year. Retrospective analysis based on the dioptric power matrix for moderate myopic and astigmatic correction. Ophthalmologe 102:235-240, 2005 Mar.

  114. Taneri S, Koch JM, Melki SA, Azar DT. Mitomycin-C assisted photorefractive keratectomy in the treatment of buttonholed laser in situ keratomileusis flaps associated with epithelial ingrowth. J Cataract Refract Surg. 31:2026-30, 2005 Oct.

  115. Taylor AW. The immunomodulating neuropeptide alpha-melanocyte-stimulating hormone (alpha-MSH) suppresses LPS-stimulated TLR4 with IRAK-M in macrophages. J Neuroimmunol. 162:43-50, 2005 May.

  116. Tomita M, Lavik E, Klassen H, Zahir T, Langer R, Young MJ. Biodegradable polymer composite grafts promote the survival and differentiation of retinal progenitor cells. Stem Cells 23:1579-1588, 2005 Nov.

  117. Treister NS, Richards SM, Lombardi MJ, Rowley P, Jensen RV, Sullivan DA. Sex-related differences in gene expression in salivary glands of BALB/c mice. J Dent Res 84:160-165, 2005 Feb.

  118. Treister NS, Richards SM, Suzuki T, Jensen RV, Sullivan DA. Influence of androgens on gene expression in the BALB/c mouse submandibular gland. J Dent Res 84:1187-1192, 2005 Dec.

  119. Van Stry M, Kazlauskas A, Schreiber SL, Symes K. Distinct effectors of platelet-derived growth factor receptor-alpha signaling are required for cell survival during embryogenesis. Proc Natl Acad Sci U S A. 102:8233-8238, 2005 Jun 7.

  120. Wagner RS, Abelson MB, Shapiro A, Torkildsen G. Evaluation of moxifloxacin, ciprofloxacin, gatifloxacin, ofloxacin, and levofloxacin concentrations in human conjunctival tissue. Arch Ophthalmol 123:1282-1283, 2005 Sep.

  121. Warfvinge K, Kiilgaard JF, Lavik EB, Scherfig E, Langer R, Klassen HJ, Young MJ. Retinal progenitor cell xenografts to the pig retina - Morphologic integration and cytochemical differentiation. Arch Ophthalmol 123:1385-1393, 2005 Oct.

  122. Yamagami S, Hamrah P, Miyamoto K, Miyazaki D, Dekaris I, Dawson T, Lu B, Gerard C, Dana MR. CCR5 chemokine receptor mediates recruitment of MHC class II-positive Langerhans cells in the mouse corneal epithelium. Invest Ophthalmol Vis Sci. 46:1201-1207, 2005 Apr.

  123. Yamagami S, Hamrah P, Zhang Q, Liu Y, Huq S, Dana MR. Early ocular chemokine gene expression and leukocyte infiltration after high-risk corneal transplantation. Mol Vis. 11:632-640, 2005 Aug 29.

  124. Yi DH, Rashid S, Cibas ES, Arrigg PG, Dana MR. Acute sacute lymphoblastic leukemia. Am J Ophthalmol. 139:719-721, 2005 Apr.

  125. Yitzhaky Y, Peli E. Vision model based image foveation and motion estimation. Opt Eng. 44:107004, 2005 Oct.

  126. Young MJ. Stem cells in the mammalian eye: a tool for retinal repair. APMIS 113:845-857, 2005 Nov.

  127. Young MJ, Borras T, Walter M, Ritch R. Tissue bioengineering - Potential applications to glaucoma. Arch Ophthalmol 123:1725-1731, 2005 Dec

  128. Zahir T, Klassen H, Young MJ. Effects of ciliary neurotrophic factor on differentiation of late retinal progenitor cells. Stem Cells 23:424-432, 2005 Mar.

  129. Zamiri P, Masli S, Kitaichi N, Taylor AW, Streilein JW. Thrombospondin plays a vital role in the immune privilege of the eye. Invest Ophthalmol Vis Sci. 46:908-919, 2005 Mar.

  130. Zebehazy KT, Zimmerman GJ, Bowers AR, Luo G, Peli E. Establishing mobility measures to assess the effectiveness of night vision devices: Results of a pilot study. J Visual Impairment Blindness 99:663-670, 2005 Oct.

  131. Zhang-Hoover J, Finn P, Stein-Streilein J. Modulation of ovalbumin-induced airway inflammation and hyperreactivity by tolerogenic APC. J Immunol. 175:7117-7124, 2005 Dec 1.

  132. Zierhut M, Stern ME, Sullivan DA, editors. Immunology of the lacrimal gland, tear film and ocular surface. London, Taylor and Francis, 2005.

SEO by Artio